Immunomic to Participate at 2018 BIO CEO & Investor Conference with Presentation and Panel Discussion

World News: . []

Immunomic Therapeutics ITI pioneering the study of investigational LAMP-based nucleic acid immunotherapy programs, announced today that the company will participate at the 2018 BIO CEO Investor Conference in two events:...

More news and information about Immunomic Therapeutics (ITI)

Published By:

Business Wire: 12:30 GMT Monday 12th February 2018

Published: .

Search for other references to "immunomic" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us